Loading clinical trials...

A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 2NCT06041841

A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity

The purpose of the study was to assess the efficacy of LB54640 in participants with rare genetic disorders of obesity

Lead sponsor: LG Chem•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

LG CHEM

CONTACT

+82-2-3777-1114 [email protected]

Related studies

COMPLETEDPhase 3

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

NCT04966741 · Bardet-Biedl Syndrome, POMC Deficiency Obesity, and more

COMPLETED

An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC, PCSK1 or LEPR Genes

NCT03621007 · POMC Deficiency Obesity, PCSK1 Deficiency Obesity, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 2, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment4

Start dateDec 2023

Last updatedNov 2, 2023

Condition

POMC Deficiency Obesity PCSK1 Deficiency Obesity LEPR Deficiency Obesity

Locations shown

Pitié Salpêtrière hospital and Sorbonne Université

Paris

Cambridge university

Cambridge

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions